- Report
- February 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,608GBP
- Report
- March 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,608GBP
- Report
- May 2024
- 133 Pages
Global
From €6138EUR$6,499USD£5,223GBP
- Report
- May 2024
- 137 Pages
Global
From €6138EUR$6,499USD£5,223GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1889EUR$2,000USD£1,607GBP
- Report
- May 2024
- 160 Pages
Global
From €4674EUR$4,949USD£3,977GBP
- Report
- October 2023
- 85 Pages
United States
From €4580EUR$4,850USD£3,898GBP
- Report
- October 2022
- 270 Pages
Global
From €3541EUR$3,750USD£3,014GBP
- Report
- February 2023
- 135 Pages
Africa
From €3541EUR$3,750USD£3,014GBP
- Report
- October 2022
- 74 Pages
Indonesia
From €3164EUR$3,350USD£2,692GBP
- Report
- February 2022
- 210 Pages
Global
From €7083EUR$7,500USD£6,027GBP
- Report
- October 2023
- 181 Pages
Global
From €4250EUR$4,500USD£3,616GBP
- Report
- January 2024
- 138 Pages
United States
€3589EUR$3,800USD£3,054GBP
- Report
- July 2023
- 200 Pages
Global
From €4250EUR$4,500USD£3,616GBP
- Report
- July 2023
- 218 Pages
Global
From €4250EUR$4,500USD£3,616GBP
- Report
- April 2023
- 93 Pages
Global
From €3500EUR$3,970USD£3,083GBP

Sulfasalazine is a drug used to treat immune disorders, such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It works by reducing inflammation and suppressing the immune system. It is usually taken orally, but can also be administered intravenously. Side effects of sulfasalazine include nausea, vomiting, and abdominal pain.
Sulfasalazine is a generic drug, meaning it is available in many different forms and from many different manufacturers. It is also available in combination with other drugs, such as methotrexate and hydroxychloroquine. The cost of sulfasalazine varies depending on the manufacturer and form.
The sulfasalazine market is highly competitive, with many different manufacturers offering their own versions of the drug. Companies in the market include Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more